PMC:7652766 / 114794-115320
Annnotations
LitCovid-PD-HP
| Id | Subject | Object | Predicate | Lexical cue | hp_id |
|---|---|---|---|---|---|
| T168 | 493-514 | Phenotype | denotes | autoimmune conditions | http://purl.obolibrary.org/obo/HP_0002960 |
LitCovid-sentences
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T566 | 0-395 | Sentence | denotes | Recent studies have demonstrated great interest in the role of corticosteroids to attenuate the pulmonary and systemic damage in COVID-19 patients because of their potent anti-inflammatory and antifibrotic properties, especially dexamethasone, a synthetic corticosteroid which is on the list of essential medicines of the World Health Organization and is readily available worldwide at low cost. |
| T567 | 396-526 | Sentence | denotes | This drug acts as a broad-spectrum immunosuppressor and has greater activity in inflammatory and autoimmune conditions (402, 403). |
LitCovid-PubTator
| Id | Subject | Object | Predicate | Lexical cue | tao:has_database_id |
|---|---|---|---|---|---|
| 4250 | 79-81 | Gene | denotes | to | Gene:6999 |
| 4251 | 138-146 | Species | denotes | patients | Tax:9606 |
| 4252 | 414-415 | Gene | denotes | a | Gene:351 |
| 4253 | 244-245 | Gene | denotes | a | Gene:351 |
| 4254 | 229-242 | Chemical | denotes | dexamethasone | MESH:D003907 |
| 4255 | 129-137 | Disease | denotes | COVID-19 | MESH:C000657245 |